Search research articles
Contact Us
Filters
Showing results (41-50 of 144) with videos related to
Page
of 15
Sort By:
Transplantation
|
August 27, 1996
Progressive accumulation of CTL with high avidity for donor antigens during the development of acute cardiac rejection
N E van Emmerik, L M Vaessen, A H Balk, et al.
Clinical and Experimental Immunology
|
December 14, 1999
T helper frequencies in peripheral blood reflect donor-directed reactivity in the graft after clinical heart transplantation
L M Vaessen, C R Daane, A P Maat, et al.
European Heart Journal
|
October 1, 1992
Too early for cardiac transplantation--the right decision?
A H Balk, M L Simoons, K Meeter, et al.
Chest
|
August 1, 1992
Diffusion capacity in heart transplant recipients
H J Groen, J M Bogaard, A H Balk, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
November 3, 2001
Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy
N de Leeuw, D J Ruiter, A H Balk, et al.
Clinical and Experimental Immunology
|
April 7, 1998
The frequency and avidity of committed cytotoxic T lymphocytes (cCTL) for donor HLA class I and class II antigens and their relation with graft vascular disease
N M van Besouw, E H Loonen, L M Vaessen, et al.
Clinical Nephrology
|
January 1, 1995
Optimising glomerular filtration rate and effective renal plasma flow measurements using a simple pharmacokinetic model
R Zietse, P J Blankestijn, B Pos, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
February 1, 1997
Cytotoxicity of graft-derived lymphocytes: specific for donor heart endothelial cells?
N H Jutte, C J Knoop, P Heijse, et al.
Transplantation
|
August 15, 1996
Human heart endothelial-cell-restricted allorecognition
N H Jutte, C J Knoop, P Heijse, et al.
Infection
|
July 1, 1993
Passive immunization against cytomegalovirus in allograft recipients. The Rotterdam Heart Transplant Program experience
A H Balk, W Weimar, P H Rothbarth, et al.
Page
of 15
Search research articles
Search
Showing results (41-50 of 144) with videos related to
Sort By:
Page
of 15
Transplantation
|
August 27, 1996
Progressive accumulation of CTL with high avidity for donor antigens during the development of acute cardiac rejection
N E van Emmerik, L M Vaessen, A H Balk, et al.
Clinical and Experimental Immunology
|
December 14, 1999
T helper frequencies in peripheral blood reflect donor-directed reactivity in the graft after clinical heart transplantation
L M Vaessen, C R Daane, A P Maat, et al.
European Heart Journal
|
October 1, 1992
Too early for cardiac transplantation--the right decision?
A H Balk, M L Simoons, K Meeter, et al.
Chest
|
August 1, 1992
Diffusion capacity in heart transplant recipients
H J Groen, J M Bogaard, A H Balk, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
November 3, 2001
Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy
N de Leeuw, D J Ruiter, A H Balk, et al.
Clinical and Experimental Immunology
|
April 7, 1998
The frequency and avidity of committed cytotoxic T lymphocytes (cCTL) for donor HLA class I and class II antigens and their relation with graft vascular disease
N M van Besouw, E H Loonen, L M Vaessen, et al.
Clinical Nephrology
|
January 1, 1995
Optimising glomerular filtration rate and effective renal plasma flow measurements using a simple pharmacokinetic model
R Zietse, P J Blankestijn, B Pos, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
February 1, 1997
Cytotoxicity of graft-derived lymphocytes: specific for donor heart endothelial cells?
N H Jutte, C J Knoop, P Heijse, et al.
Transplantation
|
August 15, 1996
Human heart endothelial-cell-restricted allorecognition
N H Jutte, C J Knoop, P Heijse, et al.
Infection
|
July 1, 1993
Passive immunization against cytomegalovirus in allograft recipients. The Rotterdam Heart Transplant Program experience
A H Balk, W Weimar, P H Rothbarth, et al.
Page
of 15